Login / Signup

Rare cutaneous manifestation of COVID-19.

Lisa KillionPaula Evelyn BeattyAsad Salim
Published in: BMJ case reports (2021)
The COVID-19 pandemic has resulted in an incomparable disease burden worldwide. One of the main contributors stems from the multisystem inflammatory syndrome associated with SARS-CoV-2 infection. The numbers of those affected continue to rise with the increasing number of confirmed COVID-19 cases. However, we are yet to fully comprehend the risk factors, disease progression and prognosis for individuals affected. We describe a case of a previously healthy 17-year-old boy who tested positive for the SARS-CoV-2 virus. He presented with a 5-day history of mild influenza-like symptoms, however, quickly required ventilatory support in the intensive care unit. Two months postdischarge, he developed an isolated petechial rash on his palms and soles. His cutaneous presentation was in association with a mixed sensorimotor peripheral neuropathy, debilitating neuropathic pain and intermittent respiratory distress. We postulate that cutaneous manifestations post-COVID-19 could be indicatory of the newly identified multisystem inflammatory syndrome.
Keyphrases
  • sars cov
  • neuropathic pain
  • coronavirus disease
  • respiratory syndrome coronavirus
  • risk factors
  • spinal cord
  • case report
  • spinal cord injury
  • functional connectivity
  • physical activity